FDA Inspection 1157734 — 3-D Matrix, Inc.

3-D Matrix, Inc. — FEI 3015528146

The FDA completed an inspection of 3-D Matrix, Inc. on Nov 17, 2021 in Newton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 17, 2021
Fiscal Year
2022
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Newton, MA (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
319021 CFR 820.30(g)Design validation acceptance criteria
320421 CFR 820.40(b)Change records, content
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
419221 CFR 806.10(a)(2)Report of violation of the Act (see 803.52(e)(9))
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.